SOX2 and neoplasm: Although previous research has shown that Sox2+ cells are more resistant to chemotherapy compared with Sox2− bulk tumor cells in SHH-MBs with wild-type p5321, the mechanism by which Sox2+ cells evade therapy remains unclear.